Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Combivent inhaler hfc 152a patents?Guselkumab brand name?Are there specific stretches to avoid while on lipitor?How much is mebendazole?
See the DrugPatentWatch profile for Daliresp
I can’t determine a specific “Daliresp generic release date” from the information provided here. A release date depends on the approved generic’s application status, labeling, and any patent/exclusivity timelines tied to the specific product and strength.
Daliresp is the brand name for roflumilast (commonly supplied as 250 mcg and 500 mcg tablets). Generic products would be expected to use the same active ingredient and generally the same strengths, but the exact release timing is driven by FDA approval and market launch.
The most dependable approach is to check the FDA’s generic-drug approval records for roflumilast and then confirm whether the approved generic has already been marketed. If you tell me the strength you care about (250 mcg vs 500 mcg) and your country (U.S. vs another market), I can narrow down what to look for and what typically determines the launch timing.
Other Questions About Daliresp :